ClearCure Biosciences
ClearCure Biosciences is a clinical-stage biopharmaceutical company focused on developing non-toxic, first-in-class and best-in-class therapies for cancer, infectious diseases, sepsis, neurological diseases, and cardiovascular conditions. The company emphasizes drugging challenging targets, leveraging proprietary small molecules, nanotechnology, new oncology cell therapies, new transdermal drug delivery technology, AI and omics-driven approaches, and digital health solutions to address serious unmet medical needs. The company is currently seeking collaborators and partnerships.
ClearCure Biosciences
24 5th Avenue Unit 1627 New York, New York 10011
ClearCure Biosciences is currently seeking investment
ClearCure Biosciences is seeking a pre-seed investment in the range of 1m-5m
What We Do
Pipeline includes a range of small molecule drugs and new molecular entities for transforming previously untreatable diseases into curable or preventable conditions. The first product to market is a non-toxic intravenous therapy for sepsis.
Application Area
Show More (1)Biologics
Digital Health Technologies
Show LessServices
Medical Devices
FDA Regulated Medical Devices
Key People
Founder, CEO
Chief Medical Officer
Medical Advisor and Key opinion Leader
Chief FDA Compliance Officer